The Debbrah Trial: Trastuzumab Deruxtecan in Her2-Positive and Her2-Low Breast Cancer Patients with Carcinomatosis
AuthID
P-017-B43
P-017-B43
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service